Mikhail Blagosklonny’s Input In Cancer Research

Mikhail Blagosklonny is an renowned oncology expert. He is based at the Roswell Park Cancer Institute where he renders his services as a professor. The scientist specializes in cancer and aging. He is the brain behind dozens of significant discoveries in the field. Mikhail studied at the First Pavlov State Medical University in Russia. He holds an MD in Internal Medicine from the St. Petersberg-based institution. After his graduation, he enrolled in same university to pursue his doctorate degree in experimental medicine and cardiology.

After completing his PhD, the scientist joined the New York Medical College. Here, he worked for a couple of years as an associate professor of medicine. His love for new challenges saw him join Ordway Research Institute. In 2009, Roswell Park Center Institute noticed his excellent skills and appointed him to serve as the professor of oncology. At the research center, he conducts various researches, including bio-gerontology, cancer, anti-aging drugs, and targeted cancer therapies. His studies are centered on understanding how targeted cancer therapies protect healthy body cells from being destroyed by various cancer cells. View Mikhail’s profile on Google Scholar

In addition, Blagosklonny works for Oncotarget as the editor-in-chief. He heads a team of scientists who review various research papers sent to the oncology journal. He also holds a similar position at Cell Cycle. Mikhail serves on the editorial board of Cell, Death and Differentiation. The professor works as an associate editor of Cancer Biology and Therapy. He has vast experience in writing and editing different papers on oncology.

Mikhail is known for developing the renowned TOR signaling hypothesis. According to the scientist, TOR signaling plays an integral role in both cancer and aging. He is a staunch supporter of rapamycin, a drug that enhances the lives of cancer patients. Most researchers sought to check on the viability of this drug. In the end, the results of their studies were positive. They confirmed that rapamycin is effective in treating aging.

The scientist has written many research papers. He has over 300 research articles, reviews, and book chapters. This makes him one of the most prolific writers in the field of Oncology. Mikhail Blagosklonny is a committed researcher who is working towards having a disease-free community. Visit classroomvoices.org to read more about Mikhail.